Drugs / Desmetramadol
Desmetramadol
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04683926 | Jan 2021 | — | Syntrix Biosystems, Inc. | Completed | No outcome recorded |
Press releases naming this drug 5 releases
| Date | Issuer | Release |
|---|---|---|
| 2019-10-30 | Syntrix Biosystems, Inc. | Syntrix Pharmaceuticals to Present Positive Desmetramadol Trial Results at the 2019 Pain Management SUMMIT syntrixbio.com ↗ |
| 2019-06-04 | Syntrix Biosystems, Inc. | Syntrix Reports Positive Clinical Trials Showing Desmetramadol Has the Analgesic and Side Effect Profile of Tramadol Without Its Metabolic Liabilities syntrixbio.com ↗ |
| 2019-03-19 | Syntrix Biosystems, Inc. | Syntrix Announces First Patient Cohort Dosed in Phase 2 Study of Desmetramadol in Diabetic Neuropathic Pain syntrixbio.com ↗ |
| 2018-12-17 | Syntrix Biosystems, Inc. | Desmetramadol featured today in new article by Research Outreach syntrixbio.com ↗ |
| 2018-03-29 | Syntrix Biosystems, Inc. | World Health Organization’s INN Approves “Desmetramadol” as Generic Name for Omnitram syntrixbio.com ↗ |
Evidence & citations 7 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Desmetramadol | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04683926 ↗ |
| Known as | Mono-o-demethyltramadol | ChEMBL registry synonym — accepted as the source's own label CHEMBL4650315 ↗ |
| Known as | O-demethyltramadol | ChEMBL registry synonym — accepted as the source's own label CHEMBL4650315 ↗ |
| Known as | O-desmethyl-cis-tramadol | ChEMBL registry synonym — accepted as the source's own label CHEMBL4650315 ↗ |
| Known as | O-dsmt | ChEMBL registry synonym — accepted as the source's own label CHEMBL4650315 ↗ |
| Modality | Small molecule | — CHEMBL4650315 ↗ |
| Route | Oral | “single oral dose of 10 mg desmetramadol” NCT04683926 ↗ |